Novartis India
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Mar 2009 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets | - | NA | 264.42 | 1,541.29 | 312.98 |
| Injectables | - | NA | NA | 206.26 | 82.23 |
| Liquid Orals/Syrups | - | NA | NA | 559.74 | 68.71 |
| Capsules | - | NA | NA | 16.71 | 28.83 |
| Creams & Ointments | - | NA | NA | 119.18 | 18.19 |
| Vials | - | NA | NA | 1,944.74 | 13.48 |
| Patches | - | NA | NA | 0.32 | 1.51 |
| Powders Others | - | NA | NA | 14.11 | 1.14 |
| Drugs & Formulations | - | NA | NA | 0.55 | 0.66 |
| Royalty Income | - | NA | NA | NA | 0.61 |
| Aqua Formulations | - | NA | NA | 0.14 | 0.00 |
| Feed Supplements | - | NA | NA | NA | 0.00 |
| Total | 528.34 | ||||
![]() | |||||
| Source : Religare Technova | |||||
![]() | |||||




Online










